TL;DR — what is Cagrilintide?
Cagrilintide is a long-acting amylin analog — a peptide that mimics the natural pancreatic hormone amylin to slow gastric emptying and enhance satiety. It works through a completely different pathway than GLP-1 agonists, which is why researchers often pair the two.
How Cagrilintide works (the science, in plain language)
Amylin is a 37-amino-acid hormone naturally co-secreted with insulin from pancreatic beta cells after a meal. Its job is to tell your brain you're full, slow how fast food leaves your stomach, and suppress glucagon. Native amylin has a half-life of just 13 minutes — useless for weekly dosing. Cagrilintide is a structurally modified amylin analog with a fatty-acid side chain that binds reversibly to albumin, extending half-life to roughly 7 days. It activates both amylin and calcitonin receptors. Because it works upstream of GLP-1 (food-volume sensing rather than glucose-response sensing), it produces additive effects when stacked with GLP-1 agonists like Semaglutide — the basis of the CagriSema research program.
What clinical research shows
A Phase-2 trial published in The Lancet (2021) evaluated Cagrilintide doses up to 4.5mg weekly in 706 participants. Mean weight reduction at 26 weeks reached 10.8% versus 3.0% in placebo. NEJM (2024) CagriSema data on the combined Cagrilintide + Semaglutide stack reported 22.7% weight reduction at 68 weeks — putting the combination in the same range as Tirzepatide.
Reference dosing from clinical trials
Consult a licensed Philippine medical professional before starting any peptide protocol. Published reference dosing typically starts at 0.16mg weekly with 4-week step-ups through 0.30mg, 0.60mg, 1.2mg, 2.4mg, and 4.5mg as the highest tested. Slow titration substantially reduces the most common side effect (nausea), which is largely transient.
Common side effects (and how individuals manage them)
- Nausea — most common at each new dose; resolves within 5–7 days.
- Decreased appetite — expected effect; ensure adequate protein.
- Constipation — from slowed gastric emptying; hydration and fiber help.
- Vomiting — less common with slow titration.
- Injection-site reactions — rotate sites.
How Cagrilintide compares to other peptides
Cagrilintide on its own produces moderate weight-reduction effects — less dramatic than Tirzepatide or Retatrutide. Its real strength shows in combination protocols. Stacked with a GLP-1 agonist, weight-reduction signals approach those of the strongest dual-incretin peptides. The mechanism is non-overlapping: GLP-1 = glucose-response satiety; amylin = volume-based satiety. Researchers studying appetite physiology often choose Cagrilintide specifically to test amylin pathway effects without GLP-1 confounders.
Buying Cagrilintide in the Philippines
Noki Labs supplies lab-tested Cagrilintide 10mg vials at ₱2,200, shipped cold-chain nationwide. Cash-on-delivery available, 1–7 day delivery, free shipping over ₱2,500 with code FREESHIP. Manila is our highest-volume city for Cagrilintide clinical-research stacks — see Peptide Supplier Manila. Go to the Cagrilintide product page or browse the Weight Management collection. Shipping info: Shipping & Delivery.
FAQ
Can Cagrilintide be used alone?
Yes — trial data supports monotherapy, but combination protocols (CagriSema) show stronger weight-reduction signals.
What's the dosing frequency?
Once-weekly subcutaneous, supported by ~7-day half-life.
How does Cagrilintide differ from natural amylin?
The fatty-acid side chain extends half-life from 13 minutes to ~7 days; receptor selectivity is broadly similar.
Is Cagrilintide stable at room temperature?
Lyophilized form is stable short-term. Reconstituted vials require refrigeration at 2–8°C.
Always consult a licensed healthcare provider before starting any new peptide or wellness regimen. Individual results vary. Statements about our products are educational and not intended to diagnose, treat, cure, or prevent any disease.
Last reviewed: May 2026 · Read more in our FAQ